This paper builds upon and extends existing studies of scientific and technological specialisation by proposing an analytical framework to compare sectoral knowledge bases across countries. It develops the concepts of knowledge persistence and knowledge integration as the relevant dimensions along which knowledge bases can be compared. Persistence is studied by analysing the evolution of specialisation over time. It hints at the cumulative, path dependent nature of learning processes. Integration is studied by analysing the evolution of specialisation across different typologies of research. It hints at the complex, non-linear interdependencies that link the scientific and technological domains. On the strength of an original database encompassing 630,000 peer-reviewed papers published between 1989 and 1996 in 11 chemistry and pharmacology-related fields across three types of research (i.e. basic, applied and development), it is argued that countries with high degrees of both persistence and integration (e.g. the US in pharmacology) are the most likely sources of useful research results for EU firms’ innovative efforts in the pharmaceutical sector. Also, some doubts are cast on the existence of a European paradox in pharmaceuticals.
The Key Characteristics of Sectoral Knowledge Bases: An International Comparison
BRUSONI, STEFANO;
2003
Abstract
This paper builds upon and extends existing studies of scientific and technological specialisation by proposing an analytical framework to compare sectoral knowledge bases across countries. It develops the concepts of knowledge persistence and knowledge integration as the relevant dimensions along which knowledge bases can be compared. Persistence is studied by analysing the evolution of specialisation over time. It hints at the cumulative, path dependent nature of learning processes. Integration is studied by analysing the evolution of specialisation across different typologies of research. It hints at the complex, non-linear interdependencies that link the scientific and technological domains. On the strength of an original database encompassing 630,000 peer-reviewed papers published between 1989 and 1996 in 11 chemistry and pharmacology-related fields across three types of research (i.e. basic, applied and development), it is argued that countries with high degrees of both persistence and integration (e.g. the US in pharmacology) are the most likely sources of useful research results for EU firms’ innovative efforts in the pharmaceutical sector. Also, some doubts are cast on the existence of a European paradox in pharmaceuticals.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
